When to Start Levodopa Therapy for Parkinson's Disease
- PMID: 30673551
- DOI: 10.1056/NEJMe1814611
When to Start Levodopa Therapy for Parkinson's Disease
Comment on
-
Randomized Delayed-Start Trial of Levodopa in Parkinson's Disease.N Engl J Med. 2019 Jan 24;380(4):315-324. doi: 10.1056/NEJMoa1809983. N Engl J Med. 2019. PMID: 30673543 Clinical Trial.
Similar articles
-
[Optimisation of treatment of Parkinson's disease with levodopa].Neurol Neurochir Pol. 2009 Sep-Oct;43(5):446-59. Neurol Neurochir Pol. 2009. PMID: 20054747 Review. Polish.
-
Strategies in the treatment of early Parkinson's disease.Acta Neurol Scand Suppl. 1993;146:50-3. Acta Neurol Scand Suppl. 1993. PMID: 8101417 Review.
-
Levodopa therapeutics for Parkinson's disease: new developments.Parkinsonism Relat Disord. 2009 Jan;15 Suppl 1:S31-4. doi: 10.1016/S1353-8020(09)70009-4. Parkinsonism Relat Disord. 2009. PMID: 19131040 Review.
-
Levodopa treatment in Parkinson's disease: how does it affect dysphagia management?Parkinsonism Relat Disord. 2014 Mar;20(3):340-1. doi: 10.1016/j.parkreldis.2013.09.013. Epub 2013 Sep 20. Parkinsonism Relat Disord. 2014. PMID: 24094704 No abstract available.
-
[Problems of long-term levodopa therapy in Parkinson's disease].Nihon Rinsho. 1997 Jan;55(1):65-71. Nihon Rinsho. 1997. PMID: 9014425 Review. Japanese.
Cited by
-
Selection of DNA aptamers that prevent the fibrillization of α-synuclein protein in cellular and mouse models.Mol Ther Nucleic Acids. 2024 Jun 15;35(3):102251. doi: 10.1016/j.omtn.2024.102251. eCollection 2024 Sep 10. Mol Ther Nucleic Acids. 2024. PMID: 39377064 Free PMC article.
-
PPARs and Their Neuroprotective Effects in Parkinson's Disease: A Novel Therapeutic Approach in α-Synucleinopathy?Int J Mol Sci. 2023 Feb 7;24(4):3264. doi: 10.3390/ijms24043264. Int J Mol Sci. 2023. PMID: 36834679 Free PMC article. Review.
-
Dopamine transporter single photon emission computed tomography (DaT-SPECT) use in the diagnosis and clinical management of parkinsonism: an 8-year retrospective study.J Neurol. 2023 May;270(5):2550-2558. doi: 10.1007/s00415-023-11563-y. Epub 2023 Feb 16. J Neurol. 2023. PMID: 36795149 Free PMC article.
-
Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.Front Cell Infect Microbiol. 2022 Aug 10;12:887407. doi: 10.3389/fcimb.2022.887407. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36034698 Free PMC article.
-
Impact of a Collaborative Pharmaceutical Care Service for Patients With Parkinson's Disease.Front Pharmacol. 2022 Jan 3;12:793361. doi: 10.3389/fphar.2021.793361. eCollection 2021. Front Pharmacol. 2022. PMID: 35046815 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical